Internal Reference Number: FOI_8211
Date Request Received: 17/10/2024 00:00:00
Date Request Replied To: 08/11/2024 00:00:00
This response was sent via: By Email
Request Summary: Ophthalmology treatments for patients
Request Category: Private Individuals
| Question Number 1: In the last 12 months of data that you have available, how many patients were treated for wet AMD (wet age-related macular degeneration) (ICD-10 Code H35.30) with the following agents: A) Bevacizumab B) Faricimab C) Ranibizumab D) Aflibercept Please answer question 1, even if it is not possible to answer question 2. | |
| Answer To Question 1: A) Bevacizumab 5 B) Faricimab 314 C) Ranibizumab <5 D) Aflibercept 486 | |
| Question Number 2: If possible to answer, in the last 12 months of data that you have available, how many other ophthalmology patients have you treated with the following agents (please list how many for each agent separately): A) Bevacizumab B) Faricimab C) Ranibizumab D) Aflibercept | |
| Answer To Question 2: A) Bevacizumab 9 B) Faricimab 122 C) Ranibizumab 0 D) Aflibercept 399 | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
